Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional meglumine antimoniate for localized cutaneous leishmaniasis
RBR-44kg5xPhase 3Recruiting
- Sponsor
- Hospital Eduardo de Menezes
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of meglumine antimoniate in cutaneous leishmaniasis (CL), sponsored by Hospital Eduardo de Menezes. Started Aug 2015; status: recruiting.
02
Drugs
meglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on RBR-44kg5x.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-44kg5x.